<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for OSIR</title>
    <link />
    <description>Headlines for Osiris Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Osiris - Can Stem Cells Lead To Profits?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1506402-osiris-can-stem-cells-lead-to-profits.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 17 Jun 2013 16:04:12 GMT</pubDate>
    </item>
    <item>
      <title>Penny-Wise, Pound-Foolish Stem Cell Stocks</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1502262-penny-wise-pound-foolish-stem-cell-stocks.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 14 Jun 2013 09:48:31 GMT</pubDate>
    </item>
    <item>
      <title>Osiris Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/30/osiris-therapeutics-to-present-at-the-jefferies-20/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 30 May 2013 17:20:43 GMT</pubDate>
    </item>
    <item>
      <title>Pipeline Progress at Gilead - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99568/pipeline-progress-at-gilead.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 16 May 2013 14:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Is the Golden Age of Blockbusters Over?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/is-the-golden-age-of-blockbusters-over/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 20:16:00 GMT</pubDate>
    </item>
    <item>
      <title>Osiris Loss In-Line with Expectations - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98971/osiris-loss-in-line-with-expectations.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 17:35:01 GMT</pubDate>
    </item>
    <item>
      <title>Osiris Therapeutics Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1409851-osiris-therapeutics-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 14:30:27 GMT</pubDate>
    </item>
    <item>
      <title>Osiris CEO: Our Stem Cell Drug With Zero Sales Is Widely Used</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11916333/1/osiris-ceo-our-stem-cell-drug-with-zero-sales-is-widely-used.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 07 May 2013 13:19:00 GMT</pubDate>
    </item>
    <item>
      <title>Osiris Therapeutics Announces First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/osiris-therapeutics-announces-first-quarter-2013-f/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 08:47:09 GMT</pubDate>
    </item>
    <item>
      <title>Loss at Aegerion Narrower Than Expected - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98642/loss-at-aegerion-narrower-than-expected.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Affymetrix Reports Disappointing 1Q - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98411/affymetrix-reports-disappointing-1q.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 02 May 2013 07:49:01 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98330/vertex-loss-lower-kalydeco-outlook-up.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 01 May 2013 08:52:01 GMT</pubDate>
    </item>
    <item>
      <title>Stem Cells: Invest At Your Own Peril</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1388421-stem-cells-invest-at-your-own-peril.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 05:33:21 GMT</pubDate>
    </item>
    <item>
      <title>Double Setback for Gilead - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98290/double-setback-for-gilead.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 30 Apr 2013 15:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Geron Narrows Loss; Cuts Jobs - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98128/geron-narrows-loss-cuts-jobs.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 29 Apr 2013 09:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Osiris Therapeutics to Present at the 12th Annual Needham Healthcare Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/29/osiris-therapeutics-to-present-at-the-12th-annual-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 29 Apr 2013 08:58:41 GMT</pubDate>
    </item>
    <item>
      <title>Biogen's Earnings Surpass Expectations - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97892/biogens-earnings-surpass-expectations.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 25 Apr 2013 11:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi's Vaccine Gets EU Approval - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97577/sanofis-vaccine-gets-eu-approval.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 22 Apr 2013 12:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Vertex CF Candidate Impresses - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97483/vertex-cf-candidate-impresses.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 19 Apr 2013 14:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Affymetrix Down to Underperform - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97066/affymetrix-down-to-underperform.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 13:50:01 GMT</pubDate>
    </item>
  </channel>
</rss>
